501 related articles for article (PubMed ID: 27092708)
1. Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people.
Ford AC; Gurusamy KS; Delaney B; Forman D; Moayyedi P
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD003840. PubMed ID: 27092708
[TBL] [Abstract][Full Text] [Related]
2. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.
Ford AC; Delaney BC; Forman D; Moayyedi P
Cochrane Database Syst Rev; 2006 Apr; (2):CD003840. PubMed ID: 16625592
[TBL] [Abstract][Full Text] [Related]
3. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.
Ford A; Delaney B; Forman D; Moayyedi P
Cochrane Database Syst Rev; 2004 Oct; (4):CD003840. PubMed ID: 15495066
[TBL] [Abstract][Full Text] [Related]
4. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.
Ford A; Delaney B; Forman D; Moayyedi P
Cochrane Database Syst Rev; 2003; (4):CD003840. PubMed ID: 14583996
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori eradication for the prevention of gastric neoplasia.
Ford AC; Forman D; Hunt R; Yuan Y; Moayyedi P
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD005583. PubMed ID: 26198377
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori eradication for the prevention of gastric neoplasia.
Ford AC; Yuan Y; Forman D; Hunt R; Moayyedi P
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD005583. PubMed ID: 32628791
[TBL] [Abstract][Full Text] [Related]
7. Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis.
Ford AC; Delaney BC; Forman D; Moayyedi P
Am J Gastroenterol; 2004 Sep; 99(9):1833-55. PubMed ID: 15330927
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers.
Arkkila PE; Seppälä K; Kosunen TU; Sipponen P; Mäkinen J; Rautelin H; Färkkilä M
Eur J Gastroenterol Hepatol; 2005 Jan; 17(1):93-101. PubMed ID: 15647648
[TBL] [Abstract][Full Text] [Related]
9. Review article: clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease.
Penston JG
Aliment Pharmacol Ther; 1996 Aug; 10(4):469-86. PubMed ID: 8853751
[TBL] [Abstract][Full Text] [Related]
10. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
11. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.
Graham DY; Lew GM; Klein PD; Evans DG; Evans DJ; Saeed ZA; Malaty HM
Ann Intern Med; 1992 May; 116(9):705-8. PubMed ID: 1558340
[TBL] [Abstract][Full Text] [Related]
12. Periodontal therapy as adjunctive treatment for gastric Helicobacter pylori infection.
Ren Q; Yan X; Zhou Y; Li WX
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD009477. PubMed ID: 26852297
[TBL] [Abstract][Full Text] [Related]
13. Indications for treatment of Helicobacter pylori infection: a systematic overview.
Veldhuyzen van Zanten SJ; Sherman PM
CMAJ; 1994 Jan; 150(2):189-98. PubMed ID: 8287341
[TBL] [Abstract][Full Text] [Related]
14. Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage.
Lai KC; Hui WM; Wong BC; Hu WH; Lam SK
Aliment Pharmacol Ther; 2000 Aug; 14(8):1071-6. PubMed ID: 10930902
[TBL] [Abstract][Full Text] [Related]
15. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group.
Peterson WL; Ciociola AA; Sykes DL; McSorley DJ; Webb DD
Aliment Pharmacol Ther; 1996 Jun; 10(3):251-61. PubMed ID: 8791947
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer.
Leodolter A; Kulig M; Brasch H; Meyer-Sabellek W; Willich SN; Malfertheiner P
Aliment Pharmacol Ther; 2001 Dec; 15(12):1949-58. PubMed ID: 11736726
[TBL] [Abstract][Full Text] [Related]
17. Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long-term follow-up study.
Wong BC; Lam SK; Lai KC; Hu WH; Ching CK; Ho J; Yuen ST; Chan CK; Lau GK; Lai CL
Aliment Pharmacol Ther; 1999 Mar; 13(3):303-9. PubMed ID: 10102962
[TBL] [Abstract][Full Text] [Related]
18. N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication.
Fontes LES; Martimbianco ALC; Zanin C; Riera R
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012357. PubMed ID: 30746681
[TBL] [Abstract][Full Text] [Related]
19. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
[TBL] [Abstract][Full Text] [Related]
20. Medical versus surgical treatment for refractory or recurrent peptic ulcer.
Gurusamy KS; Pallari E
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD011523. PubMed ID: 27025289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
